News
-
-
-
PRESS RELEASE
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Takeda Provides an Update regarding Jury Verdict in AMITIZA® (lubiprostone) Antitrust Litigation in the U.S. and Related Revision to FY2025 Financial Results
Takeda reports adverse jury verdict in AMITIZA antitrust case in the U.S., impacting FY2025 financial results. Company to pursue post-trial motions and appeal -
-
-
PRESS RELEASE
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Takeda Announces Next Steps in its Transformation to Strengthen Competitiveness and Accelerate Future Growth Outlook
Takeda announces next steps in its transformation to strengthen competitiveness and accelerate future growth outlook, positioning the company for its next era -
-
-
-
